Voluntary wheel running in dystrophin-deficient (mdx) mice: Relationships between exercise parameters and exacerbation of the dystrophic phenotype

PLoS Currents

Volumn , Issue , 2012, Pages

  Smythe, Gayle M ^a   White, Jason D ^b  

^a CHARLES STURT UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE EXACERBATION; EXERCISE; GASTROCNEMIUS MUSCLE; HISTOPATHOLOGY; MALE; MOUSE; MUSCLE INJURY; MUSCULAR DYSTROPHY; NONHUMAN; PATHOGENESIS; PHENOTYPE; QUADRICEPS FEMORIS MUSCLE; RUNNING; BEHAVIOR; IMMUNOHISTOCHEMISTRY; NECROSIS; REST; TASK PERFORMANCE;

EID: 84867451977     PISSN: None     EISSN: 21573999     Source Type: Journal    
DOI: 10.1371/currents.RRN1295     Document Type: Article

References (27)

1. Ervasti JM, Campbell KP. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol. 1993 Aug;122(4):809-23. PubMed PMID: 8349731; PubMed Central PMCID: PMC2119587.
2. Hoffman EP, Brown RH Jr, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987 Dec 24;51(6):919-28. PubMed PMID: 3319190.
3. Willmann R, Possekel S, Dubach-Powell J, Meier T, Ruegg MA. Mammalian animal models for Duchenne muscular dystrophy. Neuromuscul Disord. 2009 Apr;19(4):241-9. Epub 2009 Feb 12. Review. PubMed PMID: 19217290.
4. Grounds MD, Radley HG, Lynch GS, Nagaraju K, De Luca A. Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy. Neurobiol Dis. 2008 Jul;31(1):1-19. Epub 2008 Apr 9. Review. PubMed PMID: 18499465; PubMed Central PMCID: PMC2518169.
5. Cerri DG, Rodrigues LC, Stowell SR, Araujo DD, Coelho MC, Oliveira SR, Bizario JC, Cummings RD, Dias-Baruffi M, Costa MC. Degeneration of dystrophic or injured skeletal muscles induces high expression of Galectin-1. Glycobiology. 2008 Nov;18(11):842-50. Epub 2008 Aug 22. PubMed PMID: 18723690.
6. Ambrosio F, Ferrari RJ, Distefano G, Plassmeyer JM, Carvell GE, Deasy BM, Boninger ML, Fitzgerald GK, Huard J. The synergistic effect of treadmill running on stem-cell transplantation to heal injured skeletal muscle. Tissue Eng Part A. 2010 Mar;16(3):839-49. PubMed PMID: 19788347; PubMed Central PMCID: PMC2862616.
7. Ridgley JA, Pinniger GJ, Hamer PW, Grounds MD. The physiological effects of IGF-1 (class 1:Ea transgene) overexpression on exercise-induced damage and adaptation in dystrophic muscles of mdx mice. Pflugers Arch. 2009 Mar;457(5):1121-32. Epub 2008 Aug 26. PubMed PMID: 18726613.
8. Rooney JE, Gurpur PB, Burkin DJ. Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy. Proc Natl Acad Sci U S A. 2009 May 12;106(19):7991-6. Epub 2009 Apr 28. Erratum in: Proc Natl Acad Sci U S A. 2009 Sep 8;106(36):15514. PubMed PMID: 19416897; PubMed Central PMCID: PMC2683113.
9. Waters FJ, Shavlakadze T, McIldowie MJ, Piggott MJ, Grounds MD. Use of pifithrin to inhibit p53-mediated signalling of TNF in dystrophic muscles of mdx mice. Mol Cell Biochem. 2010 Apr;337(1-2):119-31. Epub 2009 Oct 27. PubMed PMID: 19859789.
10. De Luca A, Nico B, Rolland JF, Cozzoli A, Burdi R, Mangieri D, Giannuzzi V, Liantonio A, Cippone V, De Bellis M, Nicchia GP, Camerino GM, Frigeri A, Svelto M, Camerino DC. Gentamicin treatment in exercised mdx mice: Identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle. Neurobiol Dis. 2008 Nov;32(2):243-53. Epub 2008 Jul 23. PubMed PMID: 18694830.
11. Carter GT, Wineinger MA, Walsh SA, Horasek SJ, Abresch RT, Fowler WM Jr. Effect of voluntary wheel-running exercise on muscles of the mdx mouse. Neuromuscul Disord. 1995 Jul;5(4):323-32. PubMed PMID: 7580246.
12. Dupont-Versteegden EE, McCarter RJ, Katz MS. Voluntary exercise decreases progression of muscular dystrophy in diaphragm of mdx mice. J Appl Physiol. 1994 Oct;77(4):1736-41. PubMed PMID: 7836193.
13. Dupont-Versteegden EE. Exercise and clenbuterol as strategies to decrease the progression of muscular dystrophy in mdx mice. J Appl Physiol. 1996 Mar;80(3):734-41. PubMed PMID: 8964730.
14. Hayes A, Williams DA. Beneficial effects of voluntary wheel running on the properties of dystrophic mouse muscle. J Appl Physiol. 1996 Feb;80(2):670-9. PubMed PMID: 8929614.
15. Landisch RM, Kosir AM, Nelson SA, Baltgalvis KA, Lowe DA. Adaptive and nonadaptive responses to voluntary wheel running by mdx mice. Muscle Nerve. 2008 Oct;38(4):1290-303. PubMed PMID: 18816601.
16. Sandri M, Carraro U, Podhorska-Okolov M, Rizzi C, Arslan P, Monti D, Franceschi C. Apoptosis, DNA damage and ubiquitin expression in normal and mdx muscle fibers after exercise. FEBS Lett. 1995 Oct 16;373(3):291-5. PubMed PMID: 7589485.
17. Radley HG, Grounds MD. Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice. Neurobiol Dis. 2006 Aug;23(2):387-97. Epub 2006 Jun 23. PubMed PMID: 16798005.
18. Briguet A, Courdier-Fruh I, Foster M, Meier T, Magyar JP. Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse. Neuromuscul Disord. 2004 Oct;14(10):675-82. PubMed PMID: 15351425.
19. Hara H, Nolan PM, Scott MO, Bucan M, Wakayama Y, Fischbeck KH. Running endurance abnormality in mdx mice. Muscle Nerve. 2002 Feb;25(2):207-11. PubMed PMID: 11870688.
20. Charge SBP, Rudnicki MA. Cellular and molecular regulation of muscle regeneration. Physiol Rev. 2004 Jan;84(1):209-38. Review. PMID: 14815915.
21. Wernig A, Irintchev A, Weisshaupt P. Muscle injury, cross-sectional area and fibre type distribution in mouse soleus after intermittent wheel-running. J Physiol. 1990 Sep;428:639-52. PubMed PMID: 2231427; PubMed Central PMCID: PMC1181667.
22. Call JA, Voelker KA, Wolff AV, McMillan RP, Evans NP, Hulver MW, Talmadge RJ, Grange RW. Endurance capacity in maturing mdx mice is markedly enhanced by combined voluntary wheel running and green tea extract. J Appl Physiol. 2008 Sep;105(3):923-32. Epub 2008 Jun 26. PubMed PMID: 18583385; PubMed Central PMCID: PMC2536821.
23. Grange RW, Call JA. Recommendations to define exercise prescription for Duchenne muscular dystrophy. Exerc Sport Sci Rev. 2007 Jan;35(1):12-7. Review. PubMed PMID: 17211188.
24. Petrof BJ. The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy. Mol Cell Biochem. 1998 Feb;179(1-2):111-23. Review. PubMed PMID: 9543354.
25. Irintchev A, Wernig A. Muscle damage and repair in voluntarily running mice: strain and muscle differences. Cell Tissue Res. 1987 Sep;249(3):509-21. PubMed PMID: 3664601.
26. Roig M, Roma J, Fargas A, Munell F. Longitudinal pathologic study of the gastrocnemius muscle group in mdx mice. Acta Neuropathol. 2004 Jan;107(1):27-34. Epub 2003 Oct 7. PubMed PMID: 14530991.
27. Massa R, Silvestri G, Zeng YC, Martorana A, Sancesario G, Bernardi G. Muscle regeneration in mdx mice: resistance to repeated necrosis is compatible with myofiber maturity. Basic Appl Myol 1997; 7: 387-394.